Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APSV Dose-Finding Study in Vaccinia-Naive Adults
NCT00038987Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2002
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of wetvax in smallpox, sponsored by National Institute of Allergy and Infectious Diseases. Started May 2002; status: completed.
02
Drugs
wetvax
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT00038987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038987.